TTA’s Even Hotter July: a gloomy view on Oracle’s future, Withings gets into medical care, IKS closes TruBridge buy, Palantir/FPS contract in jeopardy, PFS’ draft telehealth provisions, more!

 

16-20 July 2026

Back into summertime doldrums with a little less news than usual. Oracle continues to depress Mr. Market with its debt load and lack of cash on hand in its ambitious transformation to an AI infrastructure landlord–but still no word about whether it can sell its EHR. But Withings makes a truly gutsy move by entering the provider fray with a CMS initiative supplementing Medicare primary care providers. IKS closes its big buy of TruBridge for $557 million in another consolidation move. NHS’ big patient database move in jeopardy if Palantir is removed. And debate on the Medicare Physician Fee Schedule and telehealth starts anew.

Please feel free to comment on the articles and pass along this Alert. Let me know if this is worth it to you! Also check out my personal page on Substack.

News roundup: Withings Medical Group service launches, MPs urge cancellation of NHS/Palantir FDP contract, IKS closes TruBridge buy for $557M, ATA comments on prelim CMS PFS for telehealth, Philips’ AI-powered…toothbrush

A gloomy view on Oracle going forward: debt, cash flow, and dependence on OpenAI

Recent Headlines, from 23andMe, to Done being Done, to Midjourney Medical scanning, to Cargo Culture

News roundup: 23andMe settles with data breach victims for $46.75M, Neuralink implants first Canadian ALS patient, Resmed selling MatrixCare EHR for $490M, Teladoc now preferred telehealth provider for NBA players

Chutes & Ladders: Done Global principals sentenced on Adderall fraud, Oracle E-Biz Suite hacked, OpenAI’s 5% offer to US government, Meta considers cloud AI, Pearl’s $110M raise

Midjourney Medical audaciously promises a revolution in whole-body scanning, powered by Butterfly Network chips. Can the reality ever match the hype?

Vinegary Must Reads This Week: Silicon Valley’s ‘Cargo Culture’; the clinical query tool explosion between OpenEvidence and general AI

Amazon’s One Medical Seniors hacked by ShinyHunters, issues “final warning” on 8.8 TB of patient data

Perspectives: The most aggressive AI adoption in healthcare is happening off the books

 * * *
Advertise on Telehealth and Telecare Aware
Support not only a publication but also a well-informed international community.

Contact Editor Donna for more information.

Help Spread the News

Please tell your colleagues about this free news service and, if you have relevant information to share with the rest of the world, please let me know!

Donna Cusano, Editor In Chief
donna.cusano@telecareaware.com

Telehealth & Telecare Aware – covering news on latest developments in telecare, telehealth and eHealth, worldwide.

News roundup: Withings Medical Group service launches, MPs urge cancellation of NHS/Palantir FDP contract, IKS closes TruBridge buy for $557M, ATA comments on prelim CMS PFS for telehealth, Philips’ AI-powered…toothbrush

Withings USA expands monitoring into clinical care services. Withings’ reach from devices into clinical care is definitely something unusual, as it’s rare that a device developer gets into the messy care space, much less with a ten-year commitment. Here Withings, with the Withings Medical Group, is entering care for Original Medicare beneficiaries via CMS’s new ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions). ACCESS is a ten-year CMS Innovation Center model that pays providers on chronic disease management outcomes. It launched on 5 July.

Withings Medical Group will concentrate on cardiovascular, kidney, and metabolic health (CKM), beginning with hypertension, diabetes, and obesity. The medical group’s care team will work with the beneficiary’s primary care providers to build an individualized care plan for each member. The Withings Medical Group teams can also prescribe and adjust medications and support the beneficiary on lifestyle changes.

From the release: “This focused scope reflects a deliberate, clinically rigorous approach to entering care, and it marks only the beginning of a broader ambition for how Withings supports health over the long term. It also aligns with the ACCESS Model’s ten-year, phased approach to testing whether outcome-aligned, technology-supported care can improve outcomes for Medicare beneficiaries nationwide.”

In the UK, two Commons committees have urged the Health Innovation Minister to cancel the contract for the NHS Federated Data Platform (FDP).  The developer, Palantir, has come under fire in both the UK and US on its ties to defense and security agencies in those countries and with Israel. Palantir contracted with NHS England starting in 2023. The Commons committees objecting to Palantir to Health Innovation Minister Preet Kaur Gill are the Health and Social Care Committee and the Science, Innovation and Technology Committee. They are urging using a contractual break in February 2027 to term the contract, seek another contractor, or develop one in the UK. The concerned Members cross parties and are joined by the trade unions and 100 NHS data and technology specialists, who have separately objected to the FDP in a letter to Health Secretary James Murray.

The FDP is a key part of NHS digital transformation to facilitate storage and analysis of health datasets to improve planning, patient care and hospital operations. But the concerns apparently are more political, targeting Palantir and alleging that its defense and security contracts will discourage patients from allowing their medical information to be used. If we in the US shared similar concerns, Microsoft, Meta, AWS, and Oracle wouldn’t have a single healthcare contract. Computing UK

IKS Health wrapped up its TruBridge buy last Thursday for $557 million. The acquisition, announced last April, closed a quarter earlier than expected. IKS is a healthcare software company for administration and documentation, with TruBridge an EHR and revenue cycle management (RCM) provider to primarily rural hospitals. The combined company now has a US customer base of 150,000 clinicians and 2,000 healthcare organizations. IKS Health is traded in India with US operations in Dallas. The TruBridge acquisition is their third this year, financed with $600 million over five years in debt sourced from Citibank, JPMorgan Chase and Deutsche Bank. TruBridge shareholders received $26.25 in cash per share as offered in April. The release is singularly unrevealing on whether TruBridge will continue as a separate product line, nor on any operational/management continuity. It is another example of consolidation and ‘line extension’ between similar companies. MedCityNews

If it’s midyear, it’s time for a preliminary CMS Physician Fee Schedule draft. ATA ACTION has an early review of its telehealth and technology changes proposed by the Centers for Medicare & Medicaid Services (CMS) that affect physicians serving Medicare beneficiaries. From the release (PDF):

  • Telehealth: In addition to changes to extend existing telehealth flexibilities, CMS proposes adding five codes to the Medicare Telehealth List, clarifying critical care consultation code descriptors, creating two new telehealth modifiers, and allowing physicians to bill for telehealth services involving residents when either the teaching physician or resident is in the room with the beneficiary.
  • Remote Patient Monitoring: CMS proposes tightening guardrails and recalculating payment for remote patient monitoring (RPM) and remote treatment monitoring (RTM) services. Key changes include restricting RTM billing to patients with an established relationship with the billing practitioner, requiring a separately reportable initiating visit tied to the start of monitoring services, prohibiting use of third-party remote monitoring companies, lowering monitoring valuations, and potentially consolidating current CPT codes into four new G-codes (two RPM, two RTM) covering initial setup and monthly monitoring/management.
  • Technology-Enabled Care: CMS is seeking broad feedback on modernizing Medicare reimbursement for technology-enabled care, with particular interest in primary care, care management, capitated payment models, and AI.
  • New–Software as a Medical Service (SaMS): Aligning with the OPPS proposed rule, CMS introduces a new category – Software as a Medical Service – defined as algorithm-based clinical decision-support software with clinical or diagnostic functionality (excluding remote monitoring and prescription digital therapeutics). SaMS providing secondary analysis of lab data would shift from the Clinical Laboratory Fee Schedule to the Physician Fee Schedule.
  • Merit-based Incentive Payment System (MIPS) Improvement Activities: CMS proposes two new technology-focused improvement activities: clinician use of AI to improve patient care, and use of interoperable clinical decision support.

Whether these survive to the Final PFS is dependent on comments, Congress, and budgets.

And now we have AI for our electronic toothbrush. Philips goes AI in its latest model, the Philips Sonicare DiamondClean 9900 Prestige. It uses built-in, on-device AI and spatially aware guidance to track brushing. There’s a 12-segment “Mouth Map” on the handle, with a light ring that gives real-time visual feedback on your coverage, pressure, and scrubbing habits. For those of us who like to press down, the SenseIQ sensor automatically adjusts intensity so we aren’t so bad. It has eight modes and three intensities, a bit more than their top-of-the-line existing Sonicares. And it comes in five premium colors! Well, well…as a faithful user of my Philips Sonicare toothbrush since a rather extensive dental  ‘remodeling’ a few years ago, and guilty of sometimes being a bit sketchy about my completeness, I am somewhat dismayed that to be au courant, I will need to acquire this new model…but it won’t be available till this fall in the US and Europe. Release, Mobihealthnews

Chutes & Ladders: Click Therapeutics raises $50M, lays off 27%; India’s IKS Health in talks to buy TruBridge for over $600M; TELCOR buys Sample for RCM expansion

So far, not a lot of ups and downs this week….

What’s both a Ladder and a Chute?

Click Therapeutics put together a healthy Series D of $50 million to commercialize its digital therapeutic for the treatment of the experiential negative symptoms of schizophrenia. That’s a cheerful earful, except for the reported 27% of their employees who just got chuted with a pink slip. In the reported range of 100-250 employees, that means 27 to 67 employees being told ‘no work for you’ after bringing the company to the commercialization point. That is a deep cut.

Boehringer Ingelheim and Click jointly developed the digital technology, which received Breakthrough Device Designation by the FDA in 2024 as an investigational technology. It provides an an adjunct to standard antipsychotic therapy through interactive psychosocial intervention techniques.

With the $50 million funding, Boehringer turned over commercialization to Click. What is odd here is that companies with investigational tech and large partners usually keep the staff lean. Commercialization and funding then means that hires change from researchers to marketers, sales, and compliance, for a net gain. The next question is…when?

Austin Speier, chief strategy officer, commented to Behavioral Health Business: “While we are incredibly excited about the potential of CT-155, that shift means making hard changes to our team to match our new commercial mission. These were not decisions we made lightly, and we are deeply grateful to everyone who helped us reach this stage.” CT-155, as it is formally known, does not yet have FDA clearance. It has a Phase III study, CONVOKE (NCT05838625), a Phase III, multicenter, randomized, double-blind, 16-week study evaluating the efficacy and safety of CT-155 versus a digital control app. Neither the BHB and FierceBiotech articles nor Click’s release reveal a timeline for FDA clearance and marketing. Which means that final FDA approval may be more distant than the funding and turnover make it appear.

Indian RCM provider IKS Health seeks to add TruBridge’s RCM for $675 million. Talks are reportedly in an advanced stage with an all-cash offer funded by a $675 million debt facility from banks like Citi, Deutsche Bank, and JP Morgan. It covers both purchase price and refinances TruBridge’s existing debt. No formal offer has been tendered to TruBridge’s board or shareholders. Surprisingly, this has gained little notice in the US healthcare press.

TruBridge provides HIT, an EHR, and RCM for health systems and practices. It is both established from the late 1990s, when RCM was new, and fairly large–it serves 1,500 healthcare organizations and employs 3,500 people with revenue of $347 million. It IPO’d in 2002 as CPSI on Nasdaq, converting to TruBridge in 2024. IKS Health is HQ’d in Mumbai but has a US HQ in Texas. It has 13,350 employees and a global base of 600 clients. It’s public on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE). In addition to RCM, it offers care coordination, risk and optimization, and utilization management tools for value-based care. Digital Health News (India)

Also in RCM, TELCOR is buying Sample Healthcare. Amount and transitions are undisclosed. Like TruBridge, TELCOR started in the late 1990s. It serves both hospital and independent labs’ RCM for billing plus point-of-care and laboratory data. It has a 57% market share in the US for point-of-care solutions and serves over 2,700 hospitals and laboratories. Sample will add an AI-driven workflow engine that will be marketed as a separate product. It received seed funding out of Y Combinator in 2024. It’s easy to determine that Sample is a tuck-in acquisition for TELCOR.  TELCOR release.